Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/811240/000156459017003972/biol-10k_20161231.htm
Exhibit 99.1
BIOLASE REPORTS 2016 FULL YEAR AND FOURTH QUARTER RESULTS
IRVINE, CA (March 8, 2017) - BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today
reported its financial results for its full year and fourth quarter ended December 31, 2016.
2016 Full Year highlights with comparisons to 2015 Full Year include:
|
• |
Worldwide revenue of $51.8 million, an increase of $3.3 million, or 7%, driven by U.S. sales |
|
o |
Worldwide Waterlase® revenue increased 8%, driven by a 15% increase in the U.S. |
|
o |
Worldwide EPIC® revenue increased 8%, driven by a 21% increase in U.S. sales |
|
o |
Worldwide imaging revenue increased $829,000, or 37% |
|
• |
Operating loss declined 25% |
|
o |
Gross margin increased to 39%, up 630 basis points due to improved pricing, geographic sales mix and increased absorption of service infrastructure expense |
|
o |
Operating expenses decreased by $595,000, or 2% |
|
• |
Cash burn rate decreased by 36% to $12.8 million for the year even with investment in new product inventories |
|
• |
Key leadership additions included: Chief Dental Officer, Vice President of Europe, the Middle East and Africa (“EMEA”), Vice President of Marketing, and Vice President of Human Resources |
|
• |
Subsequent to yearend: |
|
o |
In January 2017, received FDA clearance and launched Epic Pro™, a powerful and innovative dental diode laser system |
|
o |
In February 2017, launched Waterlase Express®, the fifth generation of the world’s most widely used all-tissue dental laser wavelength |
2016 Fourth Quarter highlights with comparisons to 2015 Fourth Quarter include:
|
• |
Worldwide revenue of $13.8 million, a decline of 5%, due to a 3% decline in U.S. sales and a 9% decline internationally |
|
o |
Worldwide Epic® revenue increased 7%, driven by a 21% increase in the U.S. |
|
o |
Worldwide imaging revenue increased $695,000, or 108%, due to high demand for intra-oral scanners |
|
o |
Quarterly average selling price of flagship Waterlase® iPlus improved |
|
o |
International decline largely driven by high prior year comparisons in China |
|
• |
Consistent gross margin of 39%, due to improved pricing and geographic sales mix |
|
• |
Internal commercial and operational readiness and reliability testing for Waterlase Express® |
|
• |
Encouraging early signs of improved growth of 32% in Germany, led by Vice President of EMEA, who joined in September 2016 |
President and CEO Harold Flynn, Jr. said “We made significant progress throughout 2016 in our most important strategic and operational goal—transforming BIOLASE into an expansive and disciplined commercial enterprise. Although lumpy, we achieved 7% revenue growth globally for the year, highlighted by double-digit revenue growth in the U.S., our most important market, within all of our core laser business. We expanded our margins and significantly cut our operating cash burn rate while building out the leadership team to take us through the next phase of development. Perhaps the best evidence of transformation is our successful execution in product development. Today, we are off and running with two new laser systems that hold promise to significantly increase the global penetration of dental lasers: the Waterlase Express, our smallest, easiest to use, most-educational, customer supportive and affordable all-tissue laser system ever; and the Epic Pro, a diode laser system created through our promising collaboration with IPG Medical that offers advancements in cutting speed, control, and precision as well as improvements in consistency and predictability.
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Biolase, Inc.
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/811240/000156459017003972/biol-10k_20161231.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years